Inactive

The Centers for Disease Control and Prevention (CDC) intends to award a fixed-price contract on a sole source basis to XCR Diagnostics, Inc., Salt Lake City, UT for primers and probes for the Laborato... The Centers for Disease Control and Prevention (CDC) intends to award a fixed-price contract on a sole source basis to XCR Diagnostics, Inc., Salt Lake City, UT for primers and probes for the Laboratory Response Network (LRN) clostridium botulinum PCR assay. The oligonucleotide components of the PCR assays are proprietary to the Vendor and cannot be reproduced or substituted by another Vendor. The North American Industry Classification System Code (NAICS) for this requirement is 325413 with a size standard of 1,250 employees. This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR Part FAR 13.106–1 (b) and 10 U.S.C. 2304 (c) (1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals. This Notice of Intent is not a request for competitive quotations; however, all quotations/responses received within five (5) calendar days of the issuance of this notice will be considered by the Government. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to the Contracting Officer, Lee Catherine Kennedy, at vhg0@cdc.gov by 10:00am ET, Sunday, 19 April 2020.